» Articles » PMID: 31620280

Goblet Cell Carcinoid of the Appendix: Two Case Reports and a Review of the Literature

Overview
Journal Mol Clin Oncol
Specialty Oncology
Date 2019 Oct 18
PMID 31620280
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Goblet cell carcinoid or carcinoma (GCC) is a rare tumor found incidentally during routine management of acute appendicitis. GCCs are more aggressive compared with conventional appendiceal tumors but less aggressive compared with adenocarcinomas, and they often present with serosal and mesoappendiceal involvement. We herein report two cases of acute appendicitis in a 45-year-old female and a 60-year-old male with varied clinical symptoms. Pathological examination of the appendix revealed the presence of adenocarcinoma with goblet cells and a Ki-67 index of 25% (grade 3) and 15% (grade 2), respectively. Subsequent right hemicolectomy was performed according to the current guidelines. No signs of disease recurrence or metastasis were detected during regular follow-up. However, the lack of a standardized classification system for GCC and the discrepancies in specific reliable markers renders their prognostic and predictive value in GCC at diagnosis insufficient. The present study also aimed to address current concerns regarding the diagnosis, treatment and prognosis of GCC, as well as the need to review and update current guidelines. To conclude, proper clinical management and the prediction of outcome for patients with GCC varies according to the classifications or staging criteria used by the clinicians; hence, a review of the current guidelines should be considered.

Citing Articles

Goblet Cell Carcinoma of the Appendix with Synchronous Adenocarcinoma of the Cecum: Distinct or Related Entities?.

Vincenti L, Andriola V, Cazzato G, Colagrande A, Fiore F Diseases. 2022; 10(4).

PMID: 36278575 PMC: 9590081. DOI: 10.3390/diseases10040077.

References
1.
Oberg K, Modlin I, de Herder W, Pavel M, Klimstra D, Frilling A . Consensus on biomarkers for neuroendocrine tumour disease. Lancet Oncol. 2015; 16(9):e435-e446. PMC: 5023063. DOI: 10.1016/S1470-2045(15)00186-2. View

2.
McCusker M, Cote T, Clegg L, Sobin L . Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer. 2002; 94(12):3307-12. DOI: 10.1002/cncr.10589. View

3.
Tsang E, McConnell Y, Schaeffer D, Lee L, Yin Y, Zerhouni S . Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix. Ann Surg Oncol. 2018; 25(8):2391-2399. DOI: 10.1245/s10434-018-6560-0. View

4.
Gagne F, Fortin P, Dufour V, Delage C . [Tumors of the appendix associating histologic features of carcinoid and adenocarcinoma]. Ann Anat Pathol (Paris). 1969; 14(4):393-406. View

5.
Yozu M, Johncilla M, Srivastava A, Ryan D, Cusack J, Doyle L . Histologic and Outcome Study Supports Reclassifying Appendiceal Goblet Cell Carcinoids as Goblet Cell Adenocarcinomas, and Grading and Staging Similarly to Colonic Adenocarcinomas. Am J Surg Pathol. 2018; 42(7):898-910. DOI: 10.1097/PAS.0000000000001056. View